Breaking News Instant updates and real-time market news.

ABUS

Arbutus Biopharma

$2.65

-0.05 (-1.85%)

, ARWR

Arrowhead

$4.39

-0.07 (-1.57%)

07:50
11/30/16
11/30
07:50
11/30/16
07:50

Arbutus Biopharma upgraded on competitor withdrawal at Chardan

As noted earlier, Chardan upgraded Arbutus (ABUS) to Buy from Neutral. Analyst Gbola Amusa upgraded the stock after Arrowhead (ARWR) announced that it was terminating its intravenously delivered RNAi clinical programs ARC-520, ARC-521, and ARC-AAT. The analyst now expects Arbutus' share of the HBV RNAi to rise to 47.5% from 17.5%. Amusa does not expect Arbutus' treatments to cause the same safety problems as those of Arrowhead. Amusa is upbeat on Arbutus' lead asset, ARB-1467. Target to $4 from $3.

ABUS

Arbutus Biopharma

$2.65

-0.05 (-1.85%)

ARWR

Arrowhead

$4.39

-0.07 (-1.57%)

  • 30

    Nov

  • 06

    Dec

ABUS Arbutus Biopharma
$2.65

-0.05 (-1.85%)

10/06/16
RBCM
10/06/16
NO CHANGE
RBCM
Alnylam news not a negative read through on other RNAi drugs, says RBC Capital
After Alnylam (ALNY) announced that it was discontinuing one of its Phase III RNAi drugs due to poor clinical outcomes, RBC Capital analyst Michael Yee does not thinks that the news indicates problems with all RNAi drugs. Rather, he thinks that RNAi was not the proper treatment for the disease that Alnylam was targeting. Other companies with RNAi treatments include The Medicines Company (MDCO0, Ionis Pharmaceuticals (IONS), Arrowhead (ARWR), and Arbutus Biopharma (ABUS).
10/14/16
CHDN
10/14/16
UPGRADE
CHDN
Neutral
Arbutus Biopharma upgraded to Neutral from Sell at Chardan
10/14/16
10/14/16
UPGRADE

Neutral
Arbutus Biopharma upgraded to Neutral on valuation at Chardan
As previously reported, Chardan upgraded Arbutus Biopharma to Neutral from Sell. Analyst MadhuKumar upgraded shares citing relative shares underperformance ahead of Q4 and 2017 clinical catalyst in the Phase IIa study of ARB-1467.
11/30/16
CHDN
11/30/16
UPGRADE
CHDN
Buy
Arbutus Biopharma upgraded to Buy from Neutral at Chardan
ARWR Arrowhead
$4.39

-0.07 (-1.57%)

11/30/16
CHDN
11/30/16
DOWNGRADE
CHDN
Neutral
Arrowhead downgraded to Neutral from Buy at Chardan
Chardan downgraded Arrowhead to Neutral and lowered its price target to $2 from $8 following the surprise announcement of its discontinuation of three clinical programs: ARC-520, ARC-521, and ARC-AAT.
11/30/16
CANT
11/30/16
DOWNGRADE
CANT
Hold
Arrowhead downgraded to Hold from Buy at Cantor
11/30/16
CANT
11/30/16
DOWNGRADE
CANT
Hold
Arrowhead downgraded on elimination of program at Cantor
As noted earlier, Cantor downgraded Arrowhead to Hold from Buy. Analyst Elemer Piros downgraded the stock after the company announced that it was terminating its intravenously delivered RNAi clinical programs ARC-520, ARC-521, and ARC-AAT but pursuing its subcutaneously delivered candidates. The analyst says that the subcutaneously delivered candidates are in early stages of development and lack visibility. Target to $1 from $15.
11/30/16
WBLR
11/30/16
DOWNGRADE
WBLR
Market Perform
Arrowhead downgraded to Market Perform from Outperform at William Blair

TODAY'S FREE FLY STORIES

WLL

Whiting Petroleum

$5.27

0.095 (1.84%)

10:20
06/22/17
06/22
10:20
06/22/17
10:20
Options
Call buyer tied to hedge in Whiting Petroleum appears closing »

Call buyer tied to hedge…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

JBL

Jabil Circuit

$29.00

-0.1 (-0.34%)

, MMP

Magellan Midstream

$68.33

0.395 (0.58%)

10:19
06/22/17
06/22
10:19
06/22/17
10:19
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…click here.

JBL

Jabil Circuit

$29.00

-0.1 (-0.34%)

MMP

Magellan Midstream

$68.33

0.395 (0.58%)

AVB

AvalonBay

$193.47

-1.09 (-0.56%)

AQMS

Aqua Metals

$11.95

-0.36 (-2.92%)

TACO

Del Taco

$13.87

0.14 (1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMX

CarMax

$61.87

2.13 (3.57%)

, DFT

DuPont Fabros

$64.48

-0.17 (-0.26%)

10:19
06/22/17
06/22
10:19
06/22/17
10:19
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…click here.

KMX

CarMax

$61.87

2.13 (3.57%)

DFT

DuPont Fabros

$64.48

-0.17 (-0.26%)

TSM

TSMC

$36.73

0.02 (0.05%)

SAND

Sandstorm Gold

$3.54

-0.0921 (-2.54%)

DAN

Dana Holding

$21.47

-0.35 (-1.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 29

    Jun

  • 30

    Jun

ORCL

Oracle

$50.78

4.45 (9.61%)

, LUV

Southwest

$61.53

0.495 (0.81%)

10:19
06/22/17
06/22
10:19
06/22/17
10:19
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…click here.

ORCL

Oracle

$50.78

4.45 (9.61%)

LUV

Southwest

$61.53

0.495 (0.81%)

ANF

Abercrombie & Fitch

$12.08

0.029 (0.24%)

KMX

CarMax

$61.87

2.13 (3.57%)

EAT

Brinker

$38.06

1.13 (3.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 26

    Jun

  • 28

    Jun

  • 29

    Jun

  • 30

    Jun

  • 07

    Jul

ATUS

Altice USA

10:18
06/22/17
06/22
10:18
06/22/17
10:18
Syndicate
Altice USA opens at $31.60, IPO priced at $30 per share »

Altice USA (ATUS) priced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

10:17
06/22/17
06/22
10:17
06/22/17
10:17
General news
Forcing Pelosi out would be 'very bad' for Republicans, Trump says »

President Donald Trump…

$NSD

NASDAQ Market Internals

10:17
06/22/17
06/22
10:17
06/22/17
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

10:16
06/22/17
06/22
10:16
06/22/17
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
06/22/17
06/22
10:15
06/22/17
10:15
General news
U.S. leading index rose 0.3% to 127.0 in May, an all time high »

U.S. leading index rose…

10:15
06/22/17
06/22
10:15
06/22/17
10:15
General news
Breaking General news story  »

Week of 6/16 EIA Natural…

SINA

SINA

$91.93

3.5 (3.96%)

, WB

Weibo

$76.96

2.88 (3.89%)

10:14
06/22/17
06/22
10:14
06/22/17
10:14
Hot Stocks
Chinese internet stocks fall following report of streaming ban »

Shares of Chinese…

SINA

SINA

$91.93

3.5 (3.96%)

WB

Weibo

$76.96

2.88 (3.89%)

FENG

Phoenix New Media

$2.69

-0.06 (-2.18%)

YY

YY

$58.98

0.89 (1.53%)

MOMO

Momo

$38.70

0.81 (2.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

ANF

Abercrombie & Fitch

$12.19

0.14 (1.16%)

10:10
06/22/17
06/22
10:10
06/22/17
10:10
Upgrade
Abercrombie & Fitch rating change  »

Abercrombie & Fitch…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HZNP

Horizon Pharma

$11.43

0.59 (5.44%)

10:10
06/22/17
06/22
10:10
06/22/17
10:10
Options
5K Horizon Pharm Jan 15 calls opened for 89c when bid-ask was 45 to 90c »

5K Horizon Pharm Jan 15…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATUS

Altice USA

10:08
06/22/17
06/22
10:08
06/22/17
10:08
Syndicate
Altice USA indicated to open at $31.50, IPO priced at $30 »

Altice USA (ATUS) priced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

CVM

CEL-SCI

$1.80

0.11 (6.51%)

10:08
06/22/17
06/22
10:08
06/22/17
10:08
Hot Stocks
Breaking Hot Stocks news story on CEL-SCI »

Cel Sci trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWTR

Twitter

$17.93

0.15 (0.84%)

10:07
06/22/17
06/22
10:07
06/22/17
10:07
Technical Analysis
Technical View: Twitter bounces higher for second session »

The shares were last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 19

    Jul

SGBX

SG Blocks

10:06
06/22/17
06/22
10:06
06/22/17
10:06
Syndicate
Breaking Syndicate news story on SG Blocks »

SG Blocks opens at $4.75,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

IGLD

Internet Gold

10:06
06/22/17
06/22
10:06
06/22/17
10:06
Hot Stocks
Breaking Hot Stocks news story on Internet Gold »

Internet Gold trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACN

Accenture

$121.52

-5.59 (-4.40%)

10:04
06/22/17
06/22
10:04
06/22/17
10:04
Technical Analysis
Technical View: Accenture trades near lows of the day »

The shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

GM

General Motors

$34.06

-0.07 (-0.21%)

10:04
06/22/17
06/22
10:04
06/22/17
10:04
Hot Stocks
GM reports 'successful' conclusion of three-year consent order with NHTSA »

General Motors reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

10:01
06/22/17
06/22
10:01
06/22/17
10:01
General news
Leading Indicators data reported »

May Leading Indicators up…

IGLD

Internet Gold

10:01
06/22/17
06/22
10:01
06/22/17
10:01
Hot Stocks
Breaking Hot Stocks news story on Internet Gold »

Internet Gold trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWTR

Twitter

$17.85

0.0699 (0.39%)

10:01
06/22/17
06/22
10:01
06/22/17
10:01
Hot Stocks
Twitter, Sela Sport announce live streaming partnership »

Twitter and Sela Sport…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 19

    Jul

QQQ

PowerShares QQQ Trust

$140.74

1.38 (0.99%)

10:00
06/22/17
06/22
10:00
06/22/17
10:00
Options
Bullish three-way spread in PowerShares QQQ »

Bullish three-way spread…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRTO

Proteon Therapeutics

10:00
06/22/17
06/22
10:00
06/22/17
10:00
Hot Stocks
Breaking Hot Stocks news story on Proteon Therapeutics »

Proteon Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.